Today, Senator Jim Banks (R-Ind.) sent a letter to the Federal Trade Commission Chairman, Andrew Ferguson, urging the ...
Trump Just Fast-Tracked Psychedelic Treatments: 3 Under-the-Radar Stocks That Could Be About to Soar
Over the weekend, President Donald Trump fast-tracked the approval process for psychedelic treatments for mental illnesses.
Eli Lilly has agreed to acquire Kelonia Therapeutics for up to $7 billion, in a deal that would bolster the buyer’s oncology ...
The private placement includes about $180 million upfront and $174 million if the company gets FDA approval for its ...
An executive order aims to speed up how quickly psychedelic drugs for mental illness can move through the regulatory process Podcaster Joe Rogan (middle right) hugs W. Bryan Hubbard, CEO of the ...
Stratasys Ltd. has returned to sequential growth and reduced cash burn, but much of its business is still struggling. Learn ...
As limited climate gains from technical methane interventions are outpaced by growth in livestock production and associated ...
Pharmaceutical powerhouse Eli Lilly & Co. will buy Boston gene therapy maker Kelonia Therapeutics for at least $3.25 billion, ...
Sen. Jim Banks argues abortion drug companies should be held to the same consumer protection standards as other ...
Surging interest in the purported benefits of psychedelic drugs has given rise to a new industry: psychedelic retreats.
Featured at this year’s meeting on early cancer research were results from an immunotherapy Merck acquired in 2024 and ...
The mRNA-based Covid vaccines helped blunt the impact of the pandemic but also sparked political backlash that has threatened ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results